New diabetes clinical trial: A Trial to Evaluate Safety, Feasibility and Efficacy of the ReCET Procedure (EMINENT-2)

Published on: August 09, 2023 at 11:00AM
Condition:   Diabetes Mellitus, Type 2
Interventions:   Device: ReCET;   Drug: Semaglutide, 1.0 mg/mL;   Other: Sham procedure
Sponsors:   Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA);   Endogenex
Recruiting
https://ift.tt/UNhETGP